Cite
HARVARD Citation
Home, P. et al. (2020). Insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis. Diabetes, obesity & metabolism. 22 (11), pp. 2179-2188. [Online].